Research And Markets Research And Markets

International Stroke Conference 2012 - Post-Conference Review and Analysis

  • ID: 2114299
  • February 2012
  • Region: Global
  • 14 pages
  • GlobalData
1 of 3

International Stroke Conference 2012 - Post-Conference Review and Analysis


GlobalData, the industry analysis specialist, has released its new conference alerts, “International Stroke Conference 2012 - Post-Conference Review and Analysis”. The conference alert is an essential source of information and analysis on the emerging therapies and new disease management techniques. The annual meeting of the International Stroke Conference 2012 was held in New Orleans, the US, on February 1-3, 2012. This two and a half day conference provides a forum in which to present recent scientific work related to cerebrovascular disease. More than 1,000 abstract presentations, lectures and debates will be featured. Some of the topics covered in the conference include clinical categories such as diagnosis, acute non-endovascular treatment, in-hospital treatment, rehabilitation and recovery, pediatric stroke, prevention, community/risk factors, nursing, emergency medicine, outcomes, vascular biology, and vascular cognitive impairment. This report aims to cover some of the scientific presentations and articles released during the conference.


The report READ MORE >

Note: Product cover images may vary from those shown
2 of 3


1.1 List of Tables
2 International Stroke Conference 2012 - Pre-conference Highlights
2.1 Full Dose IV-tPA Followed by IA Therapy for Acute Ischemic Stroke Does not Increase Morbidity or Mortality
2.2 Treatment of Acute Stroke in Patients on Dabigatran: A Survey of US Stroke Specialists
2.3 Efficacy and Safety of Rivaroxaban Compared with Warfarin among Elderly Patients with Nonvalvular Atrial Fibrillation in the ROCKET-AF Trial
2.4 Effectiveness of Early Dual Antiplatelets in Patients with TIA and Minor Stroke: Post-hoc Analysis of CLAIR Study
2.5 The Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Phase-3 Clinical Trial
2.6 Safety of tPA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery
2.7 Desmoteplase 3-9 hours after Acute Ischemic Stroke: the Ongoing DIAS-3 and DIAS-4 Clinical Trials
2.8 Triple Antiplatelets for Reducing Dependency after Ischemic Stroke (TARDIS)
2.9 Phase 2/3 Study of Intravenous Thrombolysis and Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS 2/3)
2.10 Abbreviations
2.11 Disclaimer

1.1 List of Tables
Table 1: Responses of Stroke Neurologists

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown